首页|miR-146a通过TGF-β1/SMAD通路调控脊柱结核进展的分子机制

miR-146a通过TGF-β1/SMAD通路调控脊柱结核进展的分子机制

扫码查看
目的 探讨miR-146a/转化生长因子-β(transforming growth factor-β1,TGF-β1)/母亲抗肢瘫(small mother against decapentaplegic,SMAD)通路在脊柱结核进展中的调控机制.方法 收集脊柱结核病人和正常病人髓核组织,验证miR-146a/TGF-β1/SMAD通路在结核髓核组织中的表达量;分离培养髓核细胞,敲低/过表达miR-146a,分别应用qPCR、Western blot、CCK-8、划痕实验验证miR-146a对TGF-β1/SMAD通路表达及髓核细胞增殖、迁移能力的影响.结果 与正常病人比较,脊柱结核病人髓核细胞增殖及迁移能力显著减低,miR-146a在脊柱结核病人髓核组织中表达量显著减低,而脊柱结核病人髓核组织中SMAD同系物2(SMAD2)、SMAD同系物3(SMAD3)、SMAD同系物4(SMAD4)、TGF-β1基因表达增高,SMAD同系物7(SMAD7)表达减低,提示miR-146a与TGF-β1/SMAD通路活性显著负相关.过表达miR-146a可抑制SMAD2、SMAD3、SMAD4、TGF-β1和促进SMAD7表达,而敲低miR-146a可促进SMAD2、SMAD3、SMAD4、TGF-β1 mRNA和抑制SMAD7表达水平.细胞实验进一步证实过表达miR-146a可促进脊柱结核病人髓核细胞增殖和迁移能力,而敲低miR-146a可显著抑制其增殖和迁移能力.结论 miR-146a是脊柱结核进展的关键调控因子,其可通过抑制TGF-β1/SMAD通路活性进而调控髓核细胞增殖及迁移活性.
Molecular Mechanism of miR-146a in Regulating the Progression of Spinal Tuberculosis via the TGF-β1/SMAD Pathway
Objective To explore the regulatory mechanism of miR-146a/transforming growth factor-β1(TGF-β1)/small mother against decapentaplegic(SMAD)signaling pathway in the progression of spinal tuberculosis.Methods The spinal tuberculosis nucleus pulposus tissues were collected and the expression of miR-146a/TGF-β1/SMAD signaling pathway in tuberculosis nucleus pulposus tissues was examined.The nucleus pulposus cells were isolated from tuberculosis nucleus pulposus tissues.Then miR-146a mimics and inhibitors were used to overexpress or knock down miR-146a.The effect of miR-146a on TGF-β1/SMAD signaling pathway was examined using qPCR and Western blotting assays.The effect of miR-146a on the proliferation and migration ability of nucleus pulposus cells were tested using CCK-8 and scratch assays.Results The proliferation and migration ability of nucleus pulposus cells in patients with lumbar tuberculosis was significantly reduced,and the expression level of miR-146a in the nucleus pulposus tissue of patients with lumbar tuberculosis patients was also significantly reduced.We also found that the expression of SMAD homologue 2(SMAD2),SMAD3,SMAD4,and TGF-β significantly increased,and the expression of SMAD7 was reduced,indicating that the expression of miR-146a was negatively correlated to the activity of TGF-β/SMAD pathway.Furthermore,overexpression of miR-146a significantly suppressed the expression of SMAD2,SMAD3,SMAD4,TGF-β1,but suppressed the expression of SMAD7.On the contrary,knocking down miR-146a significantly promoted the expression of SMAD2,SMAD3,SMAD4,TGF-β1,but inhibited the expression of SMAD7.We also found that overexpression of miR-146a could promote the proliferation and migration ability of tuberculosis nucleus pulposus cells,but knocking down miR-146a could significantly suppress the proliferation and migration ability of tuberculosis nucleus pulposus cells.Conclusion miR-146a is one of the key regulators of spinal tuberculosis progression,which regulates the proliferation and migration activity of nucleus pulposus cells by inhibiting the TGF-β1/SMAD pathway activity.

Spinal tuberculosismiR-146aTGF-β1/SMAD pathwayNucleus pulposus cells

李小鹏、厉锋、董阳、张扬、赵晓栋、张骁、孙泉、王军、陈高扬

展开 >

潍坊市人民医院(潍坊医学院第一附属医院)脊柱外科,山东潍坊 261200

潍坊市人民医院(潍坊医学院第一附属医院)放射科,山东潍坊 261200

潍坊市第二人民医院骨科,山东潍坊 261200

深圳市人民医院(南方科技大学第一附属医院,暨南大学第二临床医学院)手足显微血管外科,深圳市骨科研究所,深圳市运动系统组织与功能重建重点实验室(ZDSYS20200811143752005),广东深圳 518020

展开 >

脊柱结核 miR-146a TGF-β1/SMAD通路 髓核细胞

山东省医药卫生科技发展计划项目山东省自然科学基金面上项目深圳市医学三名工程项目

202004070241ZR2020MH093SZSM202111015

2024

骨科
华中科技大学同济医学院附属同济医院 中华医学会武汉分会

骨科

CSTPCD
影响因子:2.555
ISSN:1674-8573
年,卷(期):2024.15(1)
  • 4